These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35413932)

  • 1. Single vs. double intracoronary injection of mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial.
    Attar A; Nouri F; Yazdanshenas A; Hessami K; Vosough M; Abdi-Ardekani A; Izadpanah P; Ramzi M; Kojouri J; Pouladfar G; Monabati A
    Trials; 2022 Apr; 23(1):293. PubMed ID: 35413932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial.
    Attar A; Farjoud Kouhanjani M; Hessami K; Vosough M; Kojuri J; Ramzi M; Hosseini SA; Faghih M; Monabati A
    Stem Cell Res Ther; 2023 Sep; 14(1):264. PubMed ID: 37740221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8).
    Attar A; Monabati A; Montaseri M; Vosough M; Hosseini SA; Kojouri J; Abdi-Ardekani A; Izadpanah P; Azarpira N; Pouladfar G; Ramzi M
    Trials; 2022 Aug; 23(1):632. PubMed ID: 35927674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial.
    Gao LR; Chen Y; Zhang NK; Yang XL; Liu HL; Wang ZG; Yan XY; Wang Y; Zhu ZM; Li TC; Wang LH; Chen HY; Chen YD; Huang CL; Qu P; Yao C; Wang B; Chen GH; Wang ZM; Xu ZY; Bai J; Lu D; Shen YH; Guo F; Liu MY; Yang Y; Ding YC; Yang Y; Tian HT; Ding QA; Li LN; Yang XC; Hu X
    BMC Med; 2015 Jul; 13():162. PubMed ID: 26162993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction.
    Lee JW; Lee SH; Youn YJ; Ahn MS; Kim JY; Yoo BS; Yoon J; Kwon W; Hong IS; Lee K; Kwan J; Park KS; Choi D; Jang YS; Hong MK
    J Korean Med Sci; 2014 Jan; 29(1):23-31. PubMed ID: 24431901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Mesenchymal Stem Cell Therapy in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Yu J; Zhang RF; Mao YL; Zhang H
    Curr Stem Cell Res Ther; 2022; 17(8):793-807. PubMed ID: 34397334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials.
    Attar A; Bahmanzadegan Jahromi F; Kavousi S; Monabati A; Kazemi A
    Stem Cell Res Ther; 2021 Dec; 12(1):600. PubMed ID: 34876213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Wang Z; Wang L; Su X; Pu J; Jiang M; He B
    Stem Cell Res Ther; 2017 Jan; 8(1):21. PubMed ID: 28129790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial.
    Zhang R; Yu J; Zhang N; Li W; Wang J; Cai G; Chen Y; Yang Y; Liu Z
    Stem Cell Res Ther; 2021 Jan; 12(1):33. PubMed ID: 33413636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Xu JY; Liu D; Zhong Y; Huang RC
    Stem Cell Res Ther; 2017 Oct; 8(1):231. PubMed ID: 29037256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials.
    Kanelidis AJ; Premer C; Lopez J; Balkan W; Hare JM
    Circ Res; 2017 Mar; 120(7):1139-1150. PubMed ID: 28031416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
    Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
    Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction.
    Kim SH; Cho JH; Lee YH; Lee JH; Kim SS; Kim MY; Lee MG; Kang WY; Lee KS; Ahn YK; Jeong MH; Kim HS
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):329-338. PubMed ID: 29956042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.
    Zhang W; Liu XC; Yang L; Zhu DL; Zhang YD; Chen Y; Zhang HY
    Coron Artery Dis; 2013 Nov; 24(7):549-58. PubMed ID: 23892469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.
    Delewi R; Hirsch A; Tijssen JG; Schächinger V; Wojakowski W; Roncalli J; Aakhus S; Erbs S; Assmus B; Tendera M; Goekmen Turan R; Corti R; Henry T; Lemarchand P; Lunde K; Cao F; Huikuri HV; Sürder D; Simari RD; Janssens S; Wollert KC; Plewka M; Grajek S; Traverse JH; Zijlstra F; Piek JJ
    Eur Heart J; 2014 Apr; 35(15):989-98. PubMed ID: 24026778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
    Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction.
    de Jong R; van Hout GP; Houtgraaf JH; Kazemi K; Wallrapp C; Lewis A; Pasterkamp G; Hoefer IE; Duckers HJ
    Circ Cardiovasc Interv; 2014 Oct; 7(5):673-83. PubMed ID: 25294400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.